LORD, ABBETT & CO. LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 12 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$12,860,000
+15.0%
3,512,000
-13.5%
0.04%
+9.1%
Q2 2018$11,187,000
+234.4%
4,059,000
+103.0%
0.03%
+230.0%
Q2 2016$3,345,0002,000,0000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Mint Tower Capital Management B.V. 10,000,000$14,917,0003.39%
Opera Trading Capital 5,700,000$8,490,0002.38%
TFG Asset Management GP Ltd 8,100,000$12,093,0002.27%
CQS Cayman LP 18,000,000$26,872,0002.04%
BASSO CAPITAL MANAGEMENT, L.P. 6,470,000$9,632,0001.43%
Myriad Asset Management Ltd. 9,416,000$14,061,0001.04%
CAMDEN ASSET MANAGEMENT L P /CA 22,025,000$32,817,0000.85%
ANGELO GORDON & CO., L.P. 7,000,000$10,430,0000.64%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 25,000,000$37,301,0000.54%
CSS LLC/IL 5,105,000$7,617,0000.46%
View complete list of LIGAND PHARMACEUTICALS INC shareholders